This instability shows that distinguishing between ME/CFS and healthy individuals using biobanked PBMCs is a particularly challenging endeavor; since NKp46 was among the best potential candidate biomarkers identified in fresh blood samples (7), it was one of the main focuses in the present study. Here, NCR1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.